Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double‐Blind, Randomised, Phase 3 Trial ( <scp>ReSTORE</scp> China)
20250 citationsJournal Articlehybrid Open Access
Field-Weighted Citation Impact: 0.00
Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double‐Blind, Randomised, Phase 3 Trial ( <scp>ReSTORE</scp> China) | Researchclopedia